BioVie Inc. BIVI
1.61
0.00
0.00%
as of 25 Sep
- Market cap
- $13.8M
- P/E
- 0.0×
Follow BIVI
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
15.83 | 7.25 | 9.97 | 3.59 |
Net Debt/EBITDA |
4.78 | 3.31 | 2.46 | 1.57 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.59 | 0.73 | 1.41 | 0.73 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.02 | 0.02 | 0.02 | 0.02 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.58) | (0.56) | (0.99) | (0.57) | |
Cash per Share |
4.79 | 2.59 | 1.74 | 1.24 | |
Shareholders Equity per Share |
4.78 | 2.43 | 2.07 | 1.42 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
4.78 | 2.43 | 2.07 | 1.42 | |
Free Cash Flow |
(3.02) | (4.44) | (7.44) | (4.12) | |
Working Capital |
24.39 | 18.79 | 15.19 | 9.85 | |
Net Current Asset Value |
24.13 | 18.55 | 14.97 | 9.66 | |
| Other line items | |||||
Quick Ratio |
15.30 | 6.90 | 9.02 | 2.93 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.58) | (0.56) | (0.99) | (0.57) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Receivables |
— | — | — | 2.13 | |
Average Payables |
2.51 | 2.15 | 2.04 | 2.95 | |
Average Assets |
24.03 | 24.10 | 21.09 | 17.91 | |
Average Common Equity |
19.49 | 21.59 | 18.71 | 14.64 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates